Login
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc.

anika.com

What Do They Do?

Sells injectable osteoarthritis pain treatments and hyaluronic-acid-based regenerative products for tendon and cartilage repair to healthcare providers and commercial partners.

How Do They Make Money?

The company sells products to OEM partners and distributors, with sales occurring when products ship; hospital and surgery-center sales occur when products are implanted. Some partner arrangements also generate royalties tied to end-customer sales.

revenue
SegmentShareRevenue
OEM Channel
Mix

57%
FY2022: 72%
Commercial Channel
Sold outright

43%
FY2022: 28%

Who Are Their Customers?

J&J MedTech handles U.S. sales of Monovisc and Orthovisc to end customers. Anika sells regenerative products directly to clinicians, hospitals and surgery centers in the U.S., and sells internationally through distributors.

Customers above 10% of revenue, FY2025
of revenue from one customer
FY2023: 62% from one customer

Do Revenues Turn Into Profits?

Not on paper. It lost $10.9M in FY2025, but brought in more cash than it spent: $4.4M of free cash flow.

Operating income, FY2025
−10% of revenue
▼ −117% (Loss) vs FY2024 (−$5.1M, −4%)
Net income, FY2025
−10% of revenue
▲ +81% (Loss) vs FY2024 (−$56.4M, −47%)
Free cash flow, FY2025
4% of revenue
▲ Turned profitable vs FY2024 (−$2.3M, −2%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +10%
vs $27.8M in Q3 FY2025
Net income
▲ +87% (Loss)
vs −$2.3M in Q3 FY2025
OEM Channel share of revenue vs 57.0% in Q3 FY2025

Shrinking. Revenue fell 24% in 4 years, from $147.8M in FY2021 to $112.8M in FY2025, about 7% a year.

A narrower product focus The older report describes sports medicine and bone-preserving joint solutions alongside its HA products; the latest focuses on OA pain management and regenerative solutions after selling Parcus Medical and Arthrosurface.

Revenue over time
OEM Channel Commercial Channel
$200M$100M$0

Who Do They Compete With?

Competes with Sanofi Genzyme, Zimmer Biomet, Bioventus, Avanos Medical, Pacira BioSciences, Conmed, Ferring Pharmaceuticals, Arthrex, Smith & Nephew, Stryker, Atreon Orthopedics, and Bone Support

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support